Mitchell R. Humphreys, MD, Author at Grand Rounds in Urology

Mitchell R. Humphreys, MD

Mayo Clinic

Phoenix, Arizona

Mitchell R. Humphreys, MD, is a professor and chair of the Department of Urology at the Mayo Clinic in Scottsdale, Arizona. He holds dual appointments in the Department of Urology in the Mayo College of Medicine and in clinical and translational sciences in the Mayo Graduate School. In addition, he serves as Dean of the Mayo Clinic School of Continuous Professional Development. His clinical focus is on surgical and metabolic stone disease, benign prostatic hyperplasia (BPH) (with a special focus on HoLEP), and minimally invasive genitourinary oncology.

Dr. Humphreys earned his medical degree at the University of Missouri School of Medicine in Columbia, Missouri. He completed his residency at the Mayo Clinic in Rochester and an endourology and stone disease fellowship at Indiana University School of Medicine in Indianapolis. Since that time, he has been on staff at the Mayo Clinic in Arizona.

In addition to the publication of over 192 peer-reviewed manuscripts and multiple book chapters, Dr. Humphreys is a journal editor and reviewer for several international urology journals. He is an active member of the Endourology Disease Group for Excellence (EDGE) research consortium. Outside of his work with the Mayo Clinic, he serves on the Board of Directors of GSD Healthcare, LLC, promoting basic healthcare initiatives in underserved and impoverished areas around the globe. Dr. Humphreys is also the Medical Director of Bold. Forward. Unbound in Arizona.

Talks by Mitchell R. Humphreys, MD

The King of Enucleations: HoLEP

Mitchell R. Humphreys, MD | Feb 2025

Mitchell R. Humphreys, MD, MPH, delves into benign prostatic hyperplasia management and holmium laser enucleation (HoLEP).

Treating BPH: Comparing HoLEP, Rezūm, UroLift, and Aquablation

Mitchell R. Humphreys, MD | Dec 2019

Mitchell R. Humphreys, MD, reviews the current society recommendations addressing when to intervene with surgical management in patients with lower urinary tract symptoms (LUTS) secondary to benign prostatic hyperplasia (BPH). He provides an overview of new minimally-invasive surgical therapy technologies for these patients.

Updates in LUTS: Treating Overactive Bladder and Nocturia

Mitchell R. Humphreys, MD | Dec 2019

Mitchell R. Humphreys, MD, describes the shifting landscape of lower urinary tract symptoms (LUTS) management from a symptom-focused approach to a paradigm of altering the underlying disease progression. He focuses on changes in the medical management of nocturia and bladder outlet obstruction due to benign prostatic hyperplasia (BPH).